Sarepta Therapeutics spikes over 30% after announcing expanded FDA approval of Elevidys for DMD Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER AFTER EARNINGS
ALSO HIGHER
- Sarepta Therapeutics (SRPT) up 33.3% after announcing expanded FDA approval of Elevidys for DMD
- Ryan Specialty (RYAN) up 6.7% after entering S&P MidCap 400 index
- Asana (ASAN) up 4.0% after announcing $150M buyback, affirming guidance
- Evolent Health (EVH) up 2.2% after RA Capital disclosed 7.1% passive stake
- Alcoa (AA) up 1.0% after being upgraded to Overweight at Morgan Stanley
- Freeport-McMoRan (FCX) up 0.8% after being upgraded to Overweight at Morgan Stanley
DOWN AFTER EARNINGS
- Smith & Wesson Brands (SWBI) down 1.1%
ALSO LOWER
- biote (BTMD) down 1.1% after entering $60M buyback to resolve litigation
Symbols:
ASTL SRPT RYAN ASAN EVH AA FCX SWBI BTMD Keywords: fly intel, wall street, afterhours, movers, top stories, stocks
